234 related articles for article (PubMed ID: 30514359)
1. Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort study.
Panopoulos S; Tektonidou M; Drosos AA; Liossis SN; Dimitroulas T; Garyfallos A; Sakkas L; Boumpas D; Voulgari PV; Daoussis D; Thomas K; Georgiopoulos G; Vosvotekas G; Vassilopoulos D; Sfikakis PP
Arthritis Res Ther; 2018 Dec; 20(1):267. PubMed ID: 30514359
[TBL] [Abstract][Full Text] [Related]
2. Comparable or higher prevalence of comorbidities in antiphospholipid syndrome vs rheumatoid arthritis: a multicenter, case-control study.
Panopoulos S; Thomas K; Georgiopoulos G; Boumpas D; Katsiari C; Bertsias G; Drosos AA; Boki K; Dimitroulas T; Garyfallos A; Papagoras C; Katsimbri P; Tziortziotis A; Adamichou C; Kaltsonoudis E; Argyriou E; Vosvotekas G; Sfikakis PP; Vassilopoulos D; Tektonidou MG
Rheumatology (Oxford); 2021 Jan; 60(1):170-178. PubMed ID: 32596727
[TBL] [Abstract][Full Text] [Related]
3. Subclinical atherosclerosis in systemic sclerosis and rheumatoid arthritis: a comparative matched-cohort study.
Dimitroulas T; Baniotopoulos P; Pagkopoulou E; Soulaidopoulos S; Nightingale P; Sandoo A; Karagiannis A; Douglas K; Sachinidis A; Garyfallos A; Kitas G
Rheumatol Int; 2020 Dec; 40(12):1997-2004. PubMed ID: 32772133
[TBL] [Abstract][Full Text] [Related]
4. [Occurrence of cardiovascular events within a large population of patients affected by rheumatoid arthritis with or without diabetes.].
Calabria S; Ronconi G; Dondi L; Piccinni C; Pedrini A; Dondi L; Dell'Anno I; Esposito I; Addesi A; Martini N; Maggioni AP
Recenti Prog Med; 2023 Feb; 114(2):94-109. PubMed ID: 36700719
[TBL] [Abstract][Full Text] [Related]
5. Gender-associated comorbidities in rheumatoid arthritis and their impact on outcome: data from GENIRA.
Aurrecoechea E; Llorca Díaz J; Diez Lizuain ML; McGwin G; Calvo-Alen J
Rheumatol Int; 2017 Apr; 37(4):479-485. PubMed ID: 27987002
[TBL] [Abstract][Full Text] [Related]
6. Five-year incidence of common comorbidities, such as hypertension, dyslipidemia, diabetes mellitus, cardiovascular disease, cerebrovascular disease and cancer, in older Japanese patients with rheumatoid arthritis.
Mochizuki T; Ikari K; Yano K; Okazaki K
Geriatr Gerontol Int; 2019 Jul; 19(7):577-581. PubMed ID: 30950139
[TBL] [Abstract][Full Text] [Related]
7. Patients with scleroderma may have increased risk of osteoporosis. A comparison to rheumatoid arthritis and noninflammatory musculoskeletal conditions.
Yuen SY; Rochwerg B; Ouimet J; Pope JE
J Rheumatol; 2008 Jun; 35(6):1073-8. PubMed ID: 18412305
[TBL] [Abstract][Full Text] [Related]
8. Comorbidity burden in systemic sclerosis: beyond disease-specific complications.
Pagkopoulou E; Arvanitaki A; Daoussis D; Garyfallos A; Kitas G; Dimitroulas T
Rheumatol Int; 2019 Sep; 39(9):1507-1517. PubMed ID: 31300848
[TBL] [Abstract][Full Text] [Related]
9. Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype.
Chung L; Liu J; Parsons L; Hassoun PM; McGoon M; Badesch DB; Miller DP; Nicolls MR; Zamanian RT
Chest; 2010 Dec; 138(6):1383-94. PubMed ID: 20507945
[TBL] [Abstract][Full Text] [Related]
10. Comorbidity burden and clinical characteristics of patients with difficult-to-control rheumatoid arthritis.
Batko B; Urbański K; Świerkot J; Wiland P; Raciborski F; Jędrzejewski M; Koziej M; Cześnikiewicz-Guzik M; Guzik TJ; Stajszczyk M
Clin Rheumatol; 2019 Sep; 38(9):2473-2481. PubMed ID: 31076943
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous coronary intervention outcomes in patients with rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis.
Martinez SC; Mohamed M; Potts J; Abhishek A; Roddy E; Savage M; Bharadwaj A; Kwok CS; Bagur R; Mamas MA
Rheumatology (Oxford); 2020 Sep; 59(9):2512-2522. PubMed ID: 31990337
[TBL] [Abstract][Full Text] [Related]
12. Patient phenotypes in fibromyalgia comorbid with systemic sclerosis or rheumatoid arthritis: influence of diagnostic and screening tests. Screening with the FiRST questionnaire, diagnosis with the ACR 1990 and revised ACR 2010 criteria.
Perrot S; Peixoto M; Dieudé P; Hachulla E; Avouac J; Ottaviani S; Allanore Y
Clin Exp Rheumatol; 2017; 35 Suppl 105(3):35-42. PubMed ID: 28229811
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of cardiovascular comorbidities in patients with rheumatoid arthritis from a population-based cross-sectional study of a Japanese health insurance database.
Sakai R; Hirano F; Kihara M; Yokoyama W; Yamazaki H; Harada S; Nanki T; Koike R; Miyasaka N; Harigai M
Mod Rheumatol; 2016 Jul; 26(4):522-8. PubMed ID: 26666766
[TBL] [Abstract][Full Text] [Related]
14. Overlap between systemic sclerosis and rheumatoid arthritis: a distinct clinical entity?
Horimoto AM; da Costa IP
Rev Bras Reumatol Engl Ed; 2016; 56(4):287-98. PubMed ID: 27476621
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of osteoporosis and fracture in women with systemic sclerosis: a comparative study with rheumatoid arthritis.
Avouac J; Koumakis E; Toth E; Meunier M; Maury E; Kahan A; Cormier C; Allanore Y
Arthritis Care Res (Hoboken); 2012 Dec; 64(12):1871-8. PubMed ID: 22730393
[TBL] [Abstract][Full Text] [Related]
16. Erectile dysfunction associated with scleroderma: a case-control study of men with scleroderma and rheumatoid arthritis.
Hong P; Pope JE; Ouimet JM; Rullan E; Seibold JR
J Rheumatol; 2004 Mar; 31(3):508-13. PubMed ID: 14994396
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA).
Dougados M; Soubrier M; Antunez A; Balint P; Balsa A; Buch MH; Casado G; Detert J; El-Zorkany B; Emery P; Hajjaj-Hassouni N; Harigai M; Luo SF; Kurucz R; Maciel G; Mola EM; Montecucco CM; McInnes I; Radner H; Smolen JS; Song YW; Vonkeman HE; Winthrop K; Kay J
Ann Rheum Dis; 2014 Jan; 73(1):62-8. PubMed ID: 24095940
[TBL] [Abstract][Full Text] [Related]
18. Subclinical Atherosclerosis in Systemic Sclerosis: Not Less Frequent Than Rheumatoid Arthritis and Not Detected With Cardiovascular Risk Indices.
Ozen G; Inanc N; Unal AU; Korkmaz F; Sunbul M; Ozmen M; Akar S; Deniz R; Donmez S; Pamuk ON; Atagunduz P; Tigen K; Direskeneli H
Arthritis Care Res (Hoboken); 2016 Oct; 68(10):1538-46. PubMed ID: 26866424
[TBL] [Abstract][Full Text] [Related]
19. Increased risk for bone loss in women with systemic sclerosis: a comparative study with rheumatoid arthritis.
Kilic G; Kilic E; Akgul O; Ozgocmen S
Int J Rheum Dis; 2016 Apr; 19(4):405-11. PubMed ID: 24283757
[TBL] [Abstract][Full Text] [Related]
20. Chronic Inflammatory Disease Is an Independent Risk Factor for Coronary Flow Velocity Reserve Impairment Unrelated to the Processes of Coronary Artery Calcium Deposition.
Kakuta K; Dohi K; Sato Y; Yamanaka T; Kawamura M; Ogura T; Nakamori S; Fujimoto N; Fujii E; Yamada N; Ito M
J Am Soc Echocardiogr; 2016 Feb; 29(2):173-80. PubMed ID: 26443046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
